Transferrin

Transferrin

Transferrin Product List

Species
  • Human(5)
  • Mouse(2)
  • Rhesus macaque(2)
Tag
  • His Tag(3)
  • His Tag & Avi Tag(3)
  • Fc Tag(1)
  • Mouse IgG Fc Tag(1)
  • Tag Free(1)
Host
  • HEK293(9)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(3)
Grade
  • RUO(8)
  • PG (pre-GMP)(1)
Low Endotoxin
  • Yes(2)
  • No(7)
You Have Viewed 1-9 Of 9 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Human apotransferrin (Sanquin Blood Supply Foundation)Phase 3 ClinicalSanquin Plasma Products Bv
Iron Metabolism Disorders; beta-Thalassemia
Details
Delpacibart eteddesiranAOC-1001; AOC 1001Phase 3 ClinicalAvidity Biosciences Inc
Myotonic Disorders; Genetic Diseases, Inborn; Musculoskeletal Diseases; Muscular Disorders, Atrophic; Myotonic Dystrophy; Muscular Atrophy; Heredodegenerative Disorders, Nervous System; Muscular Diseases; Neuromuscular Diseases; Nervous System Diseases; Muscular Dystrophies; Neurodegenerative Diseases; Myotonia
Details
CX-2029ABBV-2029; ABBV-CX-2029; CX-2029Phase 2 ClinicalAbbvie Inc, Cytomx Therapeutics Inc
Solid tumours; Head and Neck Neoplasms; Esophageal Neoplasms; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Non-Small-Cell Lung
Details
DYNE-251DYNE251Phase 2 ClinicalDyne Therapeutics Inc
Muscular Dystrophy, Duchenne
Details
JR-446JR-446Phase 2 ClinicalJcr Pharmaceuticals Co Ltd, Medipal Holdings Corp
Mucopolysaccharidosis III
Details
JR-441JR-441Phase 2 ClinicalJcr Pharmaceuticals Co Ltd
Mucopolysaccharidosis III
Details
Lepunafusp alfaJR-171Phase 2 ClinicalJcr Pharmaceuticals Co Ltd
Mucopolysaccharidosis I
Details
PPMX-T003PPMX-T003Phase 2 ClinicalPerseus Proteomics Inc
Leukemia; Polycythemia Vera
Details
TrontinemabRO-7126209; RG-6102Phase 2 ClinicalF. Hoffmann-La Roche Ltd
Alzheimer Disease
Details
INA-03INA03Phase 1 ClinicalInatherys
Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute
Details
KK-2260KK2260; KK-2260Phase 1 ClinicalKyowa Kirin Co Ltd
Solid tumours; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck
Details
ABX-1100ABX-1100Phase 1 ClinicalAro Biotherapeutics Co
Glycogen Storage Disease Type II
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Pabinafusp alfaJR-141ApprovedJcr Pharmaceuticals Co LtdJapanMucopolysaccharidosis IIJcr Pharmaceuticals Co Ltd2021-03-23
Mucopolysaccharidosis II
Details
Customer Reviews